Drawing for LENSAI

USPTO serial 79408263

LENSAI

Reviewed by CopyMark Law Group

Reg. 7954131Status 700Registered
Filing date
Status date
Registration date
Sep 23, 2025
Examiner
CORNWELL, ANDREA B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LENSAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D. Hyra

Clifford D. Hyra FRESH IP PLC11710 Plaza America Drive, Suite 2000Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded software for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software relating to the biological, biotechnological, pharmaceutical, medical, veterinary, agricultural, and food technology research fields for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus for the analysis of biological samples, genetical, protein or sequence related data, namely, laboratory devices for detecting genetic sequences and corresponding downloadable and recorded operating system software; laboratory apparatus and instruments for the analysis of biological samples, genetical, protein or sequence related data, namely, biological microscopes and corresponding downloadable and recorded operating system software; biometric identification apparatus for laboratory purposes, namely, biometric scanners, and corresponding downloadable and recorded operating system software; downloadable cloud-based software for storing and managing electronic data in the field of biological sequence data and data linked thereto; downloadable cloud-based software for structuring, clustering, manipulating, processing and ranking data relating to the biological, biotechnological, pharmaceutical and medical research field; downloadable cloud-based software for the analysis of biological samples, genetic, protein and sequence related data; downloadable cloud-based software, for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus, namely, DNA, RNA and protein sequencers and corresponding recorded operating system software sold as a unit; devices, namely, DNA, RNA and protein sequencers for analyzing biological samples, genetical, protein or sequence related data used as scientific laboratory apparatus and related downloadable operating system software; diagnostic apparatus for biological research and laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unit; instruments for scientific laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unitACTIVE—
010Medical apparatus and instruments for use in biological, biotechnological, pharmaceutical and medical fields, namely, medical diagnostic apparatus for testing DNA, RNA and protein samples for medical and veterinary diagnostics, examination and monitoring of biological samples, genetical, protein or sequence related data; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers to identify the microbiological makeup and profile of a subject for medical diagnostic purposes; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers for the characterization of biopolymers, biological samples and biological particles for medical diagnostic purposes; apparatus for analyzing biological samples, genetical, protein or sequence related data for medical use, namely, DNA, RNA and protein sequencers for testing DNA, RNA and protein samples for medical diagnostic purposesACTIVE—
042Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based software program to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling; biological research laboratory services; biological research and analysis, and development of biological samples, genetical, protein or sequence related data for medical use; biological research laboratory services, namely, sequencing of biological samples, including DNA and RNA and analysis thereof; biological research, development and analysis of biological samples, including DNA and RNA; biological research, namely, identification and characterization of biopolymers, biological samples, biological sequences and biological particles; scientific and technological services, namely, scientific research, analysis and testing in the field of biology, biotechnology, genetics, pharmacy and medicine; biological research and analysis, and development of biotechnology; biological analysis of biological samples, genetical, protein or sequence related data for medical use; Software-as-a-service (SAAS) services featuring software to perform genetic research and analysis by applying algorithmic principles for quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modellingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 16, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 2, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 2, 2026FIMPFINAL DISPOSITION PROCESSED—
Mar 30, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 29, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 23, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 5, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 6, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 6, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 5, 2025RFNTREFUSAL PROCESSED BY IB—
Dec 13, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 28, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 27, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2024DOCKASSIGNED TO EXAMINER—
Nov 4, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 4, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance